In the US, falls in seniors have a direct medical cost of $31.3B USD annually.
Evidence indicates drugs are associated with increased falls, from both polypharmacy and taking specific classes of drugs.
Recent UBC study estimates over $400M spent in Canada on drugs for seniors that are potentially inappropriate; assuming similar ratios this translates to $3.5B in the U.S.
In-progress trials will provide data to estimate for both fall and medication fall reductions using TaperMD.
- Meta-analysis of the Impact of 9 Medication Classes on Falls in Elderly Persons [Arch Intern Med. 2009;169(21):1952-1960].
- Medical Costs of Fatal and Nonfatal Falls in Older Adults [JAGS 2018 VC 2018, Copyright the Authors Journal compilation VC 2018, The American Geriatrics Society].
- Drug-related falls in older patients: implicated drugs, consequences, and possible prevention strategies [Articles from Therapeutic Advances in Drug Safety are provided here courtesy of SAGE Publications].
- Dhalwani NN, Fahami R, Sathanapally H, et al. Association between polypharmacy and falls in older adults: a longitudinal study from England. [BMJ Open 2017;7:e016358. doi:10.1136/bmjopen-2017-016358].
- Burns E, Kakara R. Deaths from Falls Among Persons Aged ≥65 Years — United States, 2007–2016. [MMWR Morb Mortal Wkly Rep 2018;67:509–514].
- Dealths due to falls are climbing in older adults: Canadian Deprescribing Network
- Antihypertensive Medications and Serious Fall Injuries in a Nationally Representative Sample of Older Adults (JAMA Internal Medicine)
- Blood pressure pills ‘raise risk of fatal fall’ (The Telegraph)